#VisualAbstract: Obeticholic acid for the treatment of non-alcoholic steatohepatitis
1. Obeticholic acid, a farnesoid X receptor agonist, prompts fibrosis improvement in patients with non-alcoholic steatohepatitis (NASH) Evidence Rating Level: 1 ...
Tag: farnesoid X receptor agonist
Obeticholic acid for the treatment of non-alcoholic steatohepatitis
1. Obeticholic acid, a farnesoid X receptor agonist, prompts fibrosis improvement in patients with non-alcoholic steatohepatitis (NASH) Evidence Rating Level: 1 ...
2 Minute Medicine Rewind December 9, 2019
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial 1. Obeticholic ...